Celgene Corporation - Strategy, SWOT and Corporate Finance Report
Celgene Corporation - Strategy, SWOT and Corporate Finance Report
Summary
Celgene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Celgene Corporation (Celgene or 'the company') is a biopharmaceutical company that produces and sells novel therapies for the treatment of inflammatory diseases and cancer through next-generation solutions in immuno-oncology, protein homeostasis, immunology, epigenetics and neuro-inflammation. The company markets its products under Imnovid, Revlimid, Thalomid, Istodax, Abraxane, Otezla, Idhifa, Pomalyst and Vidaza brand names. It sells these products through wholesale distributors and specialty pharmacies in the US and its international sales are made directly to hospitals, clinics and retail chains, many of which are government owned. It has business presence in the US, Europe and other countries. The company is headquartered in Summit, New Jersey, the US.
Scope
Summary
Celgene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Celgene Corporation (Celgene or 'the company') is a biopharmaceutical company that produces and sells novel therapies for the treatment of inflammatory diseases and cancer through next-generation solutions in immuno-oncology, protein homeostasis, immunology, epigenetics and neuro-inflammation. The company markets its products under Imnovid, Revlimid, Thalomid, Istodax, Abraxane, Otezla, Idhifa, Pomalyst and Vidaza brand names. It sells these products through wholesale distributors and specialty pharmacies in the US and its international sales are made directly to hospitals, clinics and retail chains, many of which are government owned. It has business presence in the US, Europe and other countries. The company is headquartered in Summit, New Jersey, the US.
Scope
- Detailed information on Celgene Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celgene Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Celgene Corporation including a breakdown and examination of key business segments
- Intelligence on Celgene Corporation's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celgene Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Celgene Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Celgene Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Celgene Corporation's business structure, strategy and prospects.
Table of Contents
Company Snapshot
Celgene Corporation: Company Overview
Celgene Corporation: Overview and Key Facts
Celgene Corporation: Overview
Celgene Corporation: Key Facts
Celgene Corporation: Key Employees
Celgene Corporation: Key Employee Biographies
Celgene Corporation: Major Products and Services
Celgene Corporation: Company History
Celgene Corporation: Management Statement
Celgene Corporation: Locations and Subsidiaries
Celgene Corporation: Key Competitors
Celgene Corporation: Company Analysis
Celgene Corporation: Business Description
Celgene Corporation: SWOT Analysis
Celgene Corporation: SWOT Overview
Celgene Corporation: Strengths
Celgene Corporation: Weaknesses
Celgene Corporation: Opportunities
Celgene Corporation: Threats
Celgene Corporation: Corporate Financial Deals Activity
Celgene Corporation: Financial Deals Overview
Celgene Corporation: Targets and Partners
Celgene Corporation: Top Deals 2016 - 2020YTD*
Celgene Corporation: Advisors
Celgene Corporation: Top Legal Advisors
Celgene Corporation: Top Financial Advisors
Celgene Corporation: Mergers and Acquisitions
Celgene Corporation: Corporate Venturing
Celgene Corporation: Capital Raising
Celgene Corporation: Partnership
Celgene Corporation: Divestments
Celgene Corporation: Private Equity and Ownership
Celgene Corporation: Recent Developments
Celgene Corporation: News and Events Summary
Celgene Corporation: Contracts
Celgene Corporation: Financial Deals
Celgene Corporation: Financial Performance
Celgene Corporation: Market Developments
Celgene Corporation: Regulatory and Legal Events
Celgene Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
Company Snapshot
Celgene Corporation: Company Overview
Celgene Corporation: Overview and Key Facts
Celgene Corporation: Overview
Celgene Corporation: Key Facts
Celgene Corporation: Key Employees
Celgene Corporation: Key Employee Biographies
Celgene Corporation: Major Products and Services
Celgene Corporation: Company History
Celgene Corporation: Management Statement
Celgene Corporation: Locations and Subsidiaries
Celgene Corporation: Key Competitors
Celgene Corporation: Company Analysis
Celgene Corporation: Business Description
Celgene Corporation: SWOT Analysis
Celgene Corporation: SWOT Overview
Celgene Corporation: Strengths
Celgene Corporation: Weaknesses
Celgene Corporation: Opportunities
Celgene Corporation: Threats
Celgene Corporation: Corporate Financial Deals Activity
Celgene Corporation: Financial Deals Overview
Celgene Corporation: Targets and Partners
Celgene Corporation: Top Deals 2016 - 2020YTD*
Celgene Corporation: Advisors
Celgene Corporation: Top Legal Advisors
Celgene Corporation: Top Financial Advisors
Celgene Corporation: Mergers and Acquisitions
Celgene Corporation: Corporate Venturing
Celgene Corporation: Capital Raising
Celgene Corporation: Partnership
Celgene Corporation: Divestments
Celgene Corporation: Private Equity and Ownership
Celgene Corporation: Recent Developments
Celgene Corporation: News and Events Summary
Celgene Corporation: Contracts
Celgene Corporation: Financial Deals
Celgene Corporation: Financial Performance
Celgene Corporation: Market Developments
Celgene Corporation: Regulatory and Legal Events
Celgene Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Celgene Corporation: Key Facts
Table 2: Celgene Corporation: Key Employees
Table 3: Celgene Corporation: Company History
Table 4: Celgene Corporation: Locations and Subsidiaries
Table 5: Celgene Corporation: Key Competitors
Table 6: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Celgene Corporation: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Table 9: Celgene Corporation: Targets and Partners
Table 10: Celgene Corporation: Top Deals 2016 - 2020YTD*
Table 11: Celgene Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: Celgene Corporation: Financial Advisor Ranking by Value (US$m)
Table 13: Celgene Corporation: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Celgene Corporation: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Celgene Corporation: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 16: Celgene Corporation: Corporate Venturing by Geography (2016 - YTD*2020)
Table 17: Celgene Corporation: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 18: Celgene Corporation: Capital Raising by Deal Type (2016 - YTD*2020)
Table 19: Celgene Corporation: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 20: Celgene Corporation: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 21: Celgene Corporation: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 22: Celgene Corporation: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 23: Celgene Corporation: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 24: Celgene Corporation: News and Events Summary
Table 25: Celgene Corporation: Contracts
Table 26: Celgene Corporation: Financial Deals
Table 27: Celgene Corporation: Financial Performance
Table 28: Celgene Corporation: Market Developments
Table 29: Celgene Corporation: Regulatory and Legal Events
Table 30: Celgene Corporation: Strategy and Operations
Table 1: Celgene Corporation: Key Facts
Table 2: Celgene Corporation: Key Employees
Table 3: Celgene Corporation: Company History
Table 4: Celgene Corporation: Locations and Subsidiaries
Table 5: Celgene Corporation: Key Competitors
Table 6: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Celgene Corporation: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Table 9: Celgene Corporation: Targets and Partners
Table 10: Celgene Corporation: Top Deals 2016 - 2020YTD*
Table 11: Celgene Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: Celgene Corporation: Financial Advisor Ranking by Value (US$m)
Table 13: Celgene Corporation: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Celgene Corporation: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Celgene Corporation: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 16: Celgene Corporation: Corporate Venturing by Geography (2016 - YTD*2020)
Table 17: Celgene Corporation: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 18: Celgene Corporation: Capital Raising by Deal Type (2016 - YTD*2020)
Table 19: Celgene Corporation: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 20: Celgene Corporation: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 21: Celgene Corporation: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 22: Celgene Corporation: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 23: Celgene Corporation: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 24: Celgene Corporation: News and Events Summary
Table 25: Celgene Corporation: Contracts
Table 26: Celgene Corporation: Financial Deals
Table 27: Celgene Corporation: Financial Performance
Table 28: Celgene Corporation: Market Developments
Table 29: Celgene Corporation: Regulatory and Legal Events
Table 30: Celgene Corporation: Strategy and Operations
LIST OF FIGURES
Figure 1: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Celgene Corporation: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 3: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Figure 4: Celgene Corporation: M&A Volume and Value Trend (2016 - YTD*2020)
Figure 5: Celgene Corporation: M&A Activity by Geography (2016 - YTD*2020)
Figure 6: Celgene Corporation: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Figure 7: Celgene Corporation: Corporate Venturing by Geography (2016 - YTD*2020)
Figure 8: Celgene Corporation: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Figure 9: Celgene Corporation: Capital Raising by Deal Type (2016 - YTD*2020)
Figure 10: Celgene Corporation: Partnership Volume and Value Trend (2016 - YTD*2020)
Figure 11: Celgene Corporation: Partnership Trend by Deal Type (2016 - YTD*2020)
Figure 12: Celgene Corporation: Divestments Volume and Value Trend (2016 - YTD*2020)
Figure 13: Celgene Corporation: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Figure 14: Celgene Corporation: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Figure 1: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Celgene Corporation: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 3: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Figure 4: Celgene Corporation: M&A Volume and Value Trend (2016 - YTD*2020)
Figure 5: Celgene Corporation: M&A Activity by Geography (2016 - YTD*2020)
Figure 6: Celgene Corporation: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Figure 7: Celgene Corporation: Corporate Venturing by Geography (2016 - YTD*2020)
Figure 8: Celgene Corporation: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Figure 9: Celgene Corporation: Capital Raising by Deal Type (2016 - YTD*2020)
Figure 10: Celgene Corporation: Partnership Volume and Value Trend (2016 - YTD*2020)
Figure 11: Celgene Corporation: Partnership Trend by Deal Type (2016 - YTD*2020)
Figure 12: Celgene Corporation: Divestments Volume and Value Trend (2016 - YTD*2020)
Figure 13: Celgene Corporation: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Figure 14: Celgene Corporation: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
